AGP Executive Report
Last update: a few seconds agoFederal Marijuana Rescheduling: A key Monday deadline (Aug. 17) is set for optional post-hearing briefs in the DEA’s long-running push to move marijuana from Schedule I to Schedule III, with an advisory recommendation expected before any final decision—potentially reshaping the U.S. cannabis market, research, and state programs. Hawaii Hemp Crackdown: Hawaii’s Department of Health is tightening enforcement on hemp-derived THC products sold without medical cards, and an industry lawsuit argues the state is effectively recriminalizing federally legal hemp. Cannabis M&A: Curaleaf’s unsolicited $272M bid for Aurora Cannabis signals consolidation is accelerating, raising the odds of more takeover talk across global medical cannabis. Business & Regulation Watch: A GS1 India CEO says medicine QR codes need stronger standardization across the healthcare supply chain to better fight counterfeits and improve tracking. Drug Enforcement (Nigeria): NDLEA reports major airport and warehouse busts, including 1.55kg cocaine concealed in luggage and large codeine syrup and “Colorado” seizures, as it pushes its anti-trafficking campaign.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.